Isoliquiritigenin Derivatives Inhibit RANKL-Induced Osteoclastogenesis by Regulating p38 and NF-κB Activation in RAW 264.7 Cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Isoliquiritigenin Derivatives Inhibit RANKL-Induced Osteoclastogenesis by Regulating p38 and NF-κB Activation in RAW 264.7 Cells
Authors
Keywords
-
Journal
MOLECULES
Volume 25, Issue 17, Pages 3908
Publisher
MDPI AG
Online
2020-08-27
DOI
10.3390/molecules25173908
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antimicrobial, Antioxidant, and Anticancer Activities of Some Novel Isoxazole Ring Containing Chalcone and Dihydropyrazole Derivatives
- (2020) Afzal Shaik et al. MOLECULES
- Dietary Compound Isoliquiritigenin, an Antioxidant from Licorice, Suppresses Triple-Negative Breast Tumor Growth via Apoptotic Death Program Activation in Cell and Xenograft Animal Models
- (2020) Po-Han Lin et al. Antioxidants
- Liquiritigenin reduces osteoclast activity in zebrafish model of glucocorticoid-induced osteoporosis
- (2020) Marta Carnovali et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Isoliquiritigenin Ameliorates Acute Pancreatitis in Mice via Inhibition of Oxidative Stress and Modulation of the Nrf2/HO-1 Pathway
- (2018) Xinnong Liu et al. Oxidative Medicine and Cellular Longevity
- Isoliquiritigenin blunts osteoarthritis by inhibition of bone resorption and angiogenesis in subchondral bone
- (2018) Baochao Ji et al. Scientific Reports
- Regulation of Osteoclast Differentiation by Cytokine Networks
- (2018) Dulshara Sachini Amarasekara et al. Immune Network
- Time-lapse reveals that osteoclasts can move across the bone surface while resorbing
- (2017) Kent Søe et al. JOURNAL OF CELL SCIENCE
- Isoliquiritigenin reduces oxidative damage and alleviates mitochondrial impairment by SIRT1 activation in experimental diabetic neuropathy
- (2017) Veera Ganesh Yerra et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Isoliquiritigenin induces apoptosis and autophagy and inhibits endometrial cancer growth in mice
- (2016) Chi-Hao Wu et al. Oncotarget
- Isoliquiritigenin Attenuates Adipose Tissue Inflammation in vitro and Adipose Tissue Fibrosis through Inhibition of Innate Immune Responses in Mice
- (2016) Yasuharu Watanabe et al. Scientific Reports
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
- (2013) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- NF-κB signaling and bone resorption
- (2013) Y. Abu-Amer OSTEOPOROSIS INTERNATIONAL
- Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo
- (2012) Lingxin Zhu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Is bigger better? An argument for very low starting doses
- (2010) J. P. McCormack et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Selective Estrogen Receptor Modulators and Phytoestrogens
- (2008) Tawakalitu Oseni et al. PLANTA MEDICA
- Liquiritigenin is a plant-derived highly selective estrogen receptor β agonist
- (2007) Jennifer E. Mersereau et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started